ASCO - Pharmaphorum

Trending

ASCO

ASCO

in Partner content

Ibrance approval cemented as competition comes into view
June 7, 2016 Share
X
Ibrance approval cemented as competition comes into view
https://pharmaphorum.com/event-coverage/asco/ibrance-approval-cemented-competition-comes-view/
in Partner content

Does NEMO bring us a step closer in the fight against melanoma?
June 6, 2016 Share
X
Does NEMO bring us a step closer in the fight against melanoma?
https://pharmaphorum.com/event-coverage/asco/nemo-bring-us-step-closer-fight-melanoma/
in Partner content

The HNSCC immunotherapy race is on – and it’s going to be close
June 6, 2016 Share
X
The HNSCC immunotherapy race is on – and it’s going to be close
https://pharmaphorum.com/event-coverage/asco/hnscc-immunotherapy-race-going-close/
in Partner content

Further Darzalex results extend hope for PFS in Myeloma
June 5, 2016 Share
X
Further Darzalex results extend hope for PFS in Myeloma
https://pharmaphorum.com/partner-content/further-darzalex-results-extend-hope-for-pfs-in-myeloma/
in Partner content

Positive PIII results for VYXEOS revealed at ASCO
June 4, 2016 Share
X
Positive PIII results for VYXEOS revealed at ASCO
https://pharmaphorum.com/partner-content/positive-piii-results-for-vyxeos-revealed-at-asco/
in Partner content

What are the key presentations at ASCO 2016?
June 3, 2016 Share
X
What are the key presentations at ASCO 2016?
https://pharmaphorum.com/partner-content/what-are-the-key-presentations-at-asco-2016/
in Views and analysis

Eye on ASCO Day 3 – Pricey combos cause panic
June 6, 2016 Share
X
Eye on ASCO Day 3 – Pricey combos cause panic
https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-2-pricey-combos-cause-panic/
in Views and analysis

Eye on ASCO Day 2 – Precision medicine takes centre stage
June 5, 2016 Share
X
Eye on ASCO Day 2 – Precision medicine takes centre stage
https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-2-precision-medicine-takes-centre-stage/
in Views and analysis

Eye on ASCO Day 1 – There’s life in the old drugs yet
June 4, 2016 Share
X
Eye on ASCO Day 1 – There’s life in the old drugs yet
https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-1-theres-life-in-the-old-drugs-yet/
in Views and analysis

Eye on ASCO Day 4 – Moonshots, Money and Mobile apps
June 7, 2016 Share
X
Eye on ASCO Day 4 – Moonshots, Money and Mobile apps
https://pharmaphorum.com/event-coverage/asco-slider/day-4-moonshots-money-and-mobile-apps/

Ideathon: the project inspiring hope in clinical trials

Ideathon: the project inspiring hope in clinical trials

September 23, 2016

Innovative event aims to improve clinical trials awareness and recruitment.

X

Ideathon: the project inspiring hope in clinical trials

https://pharmaphorum.com/views-and-analysis/ideathon-project-inspiring-hope-clinical-trials/

Ibrance approval cemented as competition comes into view

Ibrance approval cemented as competition comes into view

In February 2015, Pfizer’s Ibrance (palbociclib) was granted accelerated approval by the FDA for treatment of newly diagnosed

X

Ibrance approval cemented as competition comes into view

https://pharmaphorum.com/event-coverage/asco/ibrance-approval-cemented-competition-comes-view/

Eye on ASCO Day 4 – Moonshots, Money and Mobile apps

Eye on ASCO Day 4 – Moonshots, Money and Mobile apps

You don’t often get searched by the US secret service at a medical meeting.

X

Eye on ASCO Day 4 – Moonshots, Money and Mobile apps

https://pharmaphorum.com/event-coverage/asco-slider/day-4-moonshots-money-and-mobile-apps/

Does NEMO bring us a step closer in the fight against melanoma?

Does NEMO bring us a step closer in the fight against melanoma?

Options for treatment in metastatic melanoma have increased significantly in terms of efficacy and reduction of mortality in

X

Does NEMO bring us a step closer in the fight against melanoma?

https://pharmaphorum.com/event-coverage/asco/nemo-bring-us-step-closer-fight-melanoma/

The HNSCC immunotherapy race is on – and it’s going to be close

The HNSCC immunotherapy race is on – and it’s going to be close

While improper to compare life saving treatments to buses – the metaphor when it comes to head and

X

The HNSCC immunotherapy race is on – and it’s going to be close

https://pharmaphorum.com/event-coverage/asco/hnscc-immunotherapy-race-going-close/

Eye on ASCO Day 3 – Pricey combos cause panic

Eye on ASCO Day 3 – Pricey combos cause panic

But is it pharma’s fault?

X

Eye on ASCO Day 3 – Pricey combos cause panic

https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-2-pricey-combos-cause-panic/

Further Darzalex results extend hope for PFS in Myeloma

Further Darzalex results extend hope for PFS in Myeloma

Earlier this year (March), Johnson & Johnson announced that the randomized Phase III CASTOR trial (NCT02136134) achieved its

X

Further Darzalex results extend hope for PFS in Myeloma

https://pharmaphorum.com/partner-content/further-darzalex-results-extend-hope-for-pfs-in-myeloma/

Eye on ASCO Day 2 – Precision medicine takes centre stage

Eye on ASCO Day 2 – Precision medicine takes centre stage

Data from one of the largest cancer genomics studies ever conducted.

X

Eye on ASCO Day 2 – Precision medicine takes centre stage

https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-2-precision-medicine-takes-centre-stage/

Positive PIII results for VYXEOS revealed at ASCO

Positive PIII results for VYXEOS revealed at ASCO

Building on the announcement made in March of this year, Celator Pharmaceuticals has today (June 4th) presented the

X

Positive PIII results for VYXEOS revealed at ASCO

https://pharmaphorum.com/partner-content/positive-piii-results-for-vyxeos-revealed-at-asco/

Eye on ASCO Day 1 – There’s life in the old drugs yet

Eye on ASCO Day 1 – There’s life in the old drugs yet

The American Society of Clinical Oncology meeting, the world’s biggest cancer conference, has kicked off in blazing sunshine

X

Eye on ASCO Day 1 – There’s life in the old drugs yet

https://pharmaphorum.com/views-and-analysis/eye-on-asco-day-1-theres-life-in-the-old-drugs-yet/

What are the key presentations at ASCO 2016?

What are the key presentations at ASCO 2016?

The 2016 American Society of Clinical Oncology (ASCO) annual meeting starts today (3rd June), and it promises to

X

What are the key presentations at ASCO 2016?

https://pharmaphorum.com/partner-content/what-are-the-key-presentations-at-asco-2016/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com